Historically, the week of Thanksgiving is one of the busiest for travel. But with the US reporting its 20th day in a row of more than 100,000 new cases Sunday, the US Centers for Disease Control and Prevention advised against traveling for the holiday this year to decrease risk of spreading infections.
Health experts have long worried that the colder months could drive people indoors, leading to a rise in infection rates. On Friday, the CDC said that 50% of cases are spread by people without symptoms. With just one infected person having the potential to cause an outbreak, experts worry that people traveling and gathering could prove dangerous to the American public that is still in the thick of the pandemic.
State leaders warn against superspreader events
As the pandemic devastates regions across the country, many state leaders are urging residents to follow recommended guidelines.
Oregon reported a record high for three days in a row with 1,517 new cases on Sunday. Gov. Kate Brown ordered a two week “social freeze” on November 18 and warned residents Sunday not to attend large Thanksgiving gatherings.
In Nevada, cases are rising at “wildfire level,” Gov. Steve Sisolak said. He announced new restrictions will begin Tuesday, including a mask mandate indoors and outdoors for residents and visitors, limiting private gatherings to ten people or less and requiring restaurant reservations to be for no more than four people at a table.
“Right now they’re helping us with the overflow of transporting where the trailers are, trying to get some movement so we don’t have any backup,” Samaniego told KVIA. “We’ve got a lot of loved ones waiting for relatives and moms and dads.”
On Friday, Samaniego sent a letter to Texas Gov. Greg Abbott in hopes of reinstating a curfew for El Paso county as Covid-19 cases continue to surge in the area.
Promising vaccine developments
Americans likely still have a while to wait for a vaccine, but there are promising developments in the research.
The US Food and Drug Administration has set a meeting December 10 for the Vaccines and Related Biological Products Advisory Committee to discuss an emergency use authorization request for a vaccine candidate, FDA Commissioner Dr. Stephen Hahn tweeted on Sunday.
“While we can’t predict how long FDA’s review will take, the agency will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner, so that we can help make available a vaccine